Cardiovascular prevention—end of the road for niacin?
Crossref DOI link: https://doi.org/10.1038/nrendo.2014.159
Published Online: 2014-09-02
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tuteja, Sony
Rader, Daniel J.
Text and Data Mining valid from 2014-09-02
Article History
First Online: 2 September 2014
Competing interests
: D.J.R has been a consultant for Merck and Eli Lilly. S.T. declares no competing interests.